| A THIRD PROTEOLYTIC CLEAVAGE RELEASES NICD | 0 | 1 | 1 | 10 | 0 |
| ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | 0 | 1 | 1 | 23 | 0 |
| ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | 0 | 1 | 1 | 11 | 0 |
| ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | 0 | 1 | 1 | 17 | 0 |
| ACTIVATED TLR4 SIGNALLING | 0 | 1 | 1 | 23 | 0 |
| ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | 0 | 1 | 1 | 37 | 0 |
| ACTIVATION OF BH3 ONLY PROTEINS | 0 | 1 | 1 | 16 | 0 |
| ACTIVATION OF THE PRE REPLICATIVE COMPLEX | 0 | 1 | 1 | 30 | 0 |
| ADENYLATE CYCLASE ACTIVATING PATHWAY | 0 | 1 | 1 | 11 | 0 |
| ADHERENS JUNCTIONS INTERACTIONS | 0 | 1 | 1 | 29 | 0 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1 | 0 | 1 | 1 | 25 | 0 |
| AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | 0 | 1 | 1 | 14 | 0 |
| AMINE DERIVED HORMONES | 0 | 1 | 1 | 11 | 0 |
| AMINE LIGAND BINDING RECEPTORS | 0 | 1 | 1 | 40 | 0 |
| AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | 0 | 1 | 1 | 47 | 0 |
| AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | 0 | 1 | 1 | 30 | 0 |
| APCDC20 MEDIATED DEGRADATION OF CYCLIN B | 0 | 1 | 1 | 17 | 0 |
| APOPTOSIS | 0 | 1 | 1 | 129 | 0 |
| APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | 0 | 1 | 1 | 11 | 0 |
| APOPTOTIC EXECUTION PHASE | 0 | 1 | 1 | 48 | 0 |
| AUTODEGRADATION OF CDH1 BY CDH1 APC | 0 | 1 | 1 | 57 | 0 |
| AXON GUIDANCE | 0 | 1 | 1 | 160 | 0 |
| BASE EXCISION REPAIR | 0 | 1 | 1 | 18 | 0 |
| BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | 0 | 1 | 1 | 10 | 0 |
| BASIGIN INTERACTIONS | 0 | 1 | 1 | 25 | 0 |
| BIOLOGICAL OXIDATIONS | 0 | 1 | 1 | 123 | 0 |
| BRANCHED CHAIN AMINO ACID CATABOLISM | 0 | 1 | 1 | 17 | 0 |
| CALCITONIN LIKE LIGAND RECEPTORS | 0 | 1 | 1 | 10 | 0 |
| CAM PATHWAY | 0 | 1 | 1 | 24 | 0 |
| CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | 0 | 1 | 1 | 12 | 0 |
| CD28 CO STIMULATION | 0 | 1 | 1 | 28 | 0 |
| CD28 DEPENDENT PI3K AKT SIGNALING | 0 | 1 | 1 | 19 | 0 |
| CD28 DEPENDENT VAV1 PATHWAY | 0 | 1 | 1 | 11 | 0 |
| CDC20 PHOSPHO APC MEDIATED DEGRADATION OF CYCLIN A | 0 | 1 | 1 | 62 | 0 |
| CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | 0 | 1 | 1 | 52 | 0 |
| CELL CELL ADHESION SYSTEMS | 0 | 1 | 1 | 58 | 0 |
| CELL CYCLE CHECKPOINTS | 0 | 1 | 1 | 109 | 0 |
| CELL CYCLE MITOTIC | 0 | 1 | 1 | 302 | 0 |
| CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | 0 | 1 | 1 | 61 | 0 |
| CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | 0 | 1 | 1 | 91 | 0 |
| CENTROSOME MATURATION | 0 | 1 | 1 | 69 | 0 |
| CHAPERONIN MEDIATED PROTEIN FOLDING | 0 | 1 | 1 | 47 | 0 |
| CHEMOKINE RECEPTORS BIND CHEMOKINES | 0 | 1 | 1 | 54 | 0 |
| CHOLESTEROL BIOSYNTHESIS | 0 | 1 | 1 | 21 | 0 |
| CHYLOMICRON MEDIATED LIPID TRANSPORT | 0 | 1 | 1 | 17 | 0 |
| CITRIC ACID CYCLE | 0 | 1 | 1 | 19 | 0 |
| CLASS A1 RHODOPSIN LIKE RECEPTORS | 0 | 1 | 1 | 283 | 0 |
| CLASS B2 SECRETIN FAMILY RECEPTORS | 0 | 1 | 1 | 85 | 0 |
| CLASS C3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | 0 | 1 | 1 | 15 | 0 |
| CLATHRIN DERIVED VESICLE BUDDING | 0 | 1 | 1 | 60 | 0 |
| COLLAGEN MEDIATED ACTIVATION CASCADE | 0 | 1 | 1 | 21 | 0 |
| COMMON PATHWAY | 0 | 1 | 1 | 14 | 0 |
| COMPLEMENT CASCADE | 0 | 1 | 1 | 20 | 0 |
| CONVERSION FROM APC CDC20 TO APC CDH1 IN LATE ANAPHASE | 0 | 1 | 1 | 17 | 0 |
| COPI MEDIATED TRANSPORT | 0 | 1 | 1 | 10 | 0 |
| COSTIMULATION BY THE CD28 FAMILY | 0 | 1 | 1 | 65 | 0 |
| CRMPS IN SEMA3A SIGNALING | 0 | 1 | 1 | 16 | 0 |
| CTLA4 INHIBITORY SIGNALING | 0 | 1 | 1 | 20 | 0 |
| CYCLIN A1 ASSOCIATED EVENTS DURING G2 M TRANSITION | 0 | 1 | 1 | 13 | 0 |
| CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | 0 | 1 | 1 | 58 | 0 |
| CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | 0 | 1 | 1 | 47 | 0 |
| CYTOSOLIC SULFONATION OF SMALL MOLECULES | 0 | 1 | 1 | 10 | 0 |
| CYTOSOLIC TRNA AMINOACYLATION | 0 | 1 | 1 | 22 | 0 |
| DARPP32 EVENTS | 0 | 1 | 1 | 24 | 0 |
| DEATH RECEPTOR SIGNALLING | 0 | 1 | 1 | 13 | 0 |
| DIABETES PATHWAYS | 0 | 1 | 1 | 381 | 0 |
| DNA REPAIR | 0 | 1 | 1 | 102 | 0 |
| DNA REPLICATION PRE INITIATION | 0 | 1 | 1 | 76 | 0 |
| DNA STRAND ELONGATION | 0 | 1 | 1 | 31 | 0 |
| DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | 0 | 1 | 1 | 13 | 0 |
| DOUBLE STRAND BREAK REPAIR | 0 | 1 | 1 | 20 | 0 |
| DOWN STREAM SIGNAL TRANSDUCTION | 0 | 1 | 1 | 35 | 0 |
| DOWNSTREAM EVENTS IN GPCR SIGNALING | 0 | 1 | 1 | 438 | 0 |
| DOWNSTREAM TCR SIGNALING | 0 | 1 | 1 | 43 | 0 |
| DUAL INCISION REACTION IN GG NER | 0 | 1 | 1 | 19 | 0 |
| DUAL INCISION REACTION IN TC NER | 0 | 1 | 1 | 27 | 0 |
| E2F MEDIATED REGULATION OF DNA REPLICATION | 0 | 1 | 1 | 32 | 0 |
| E2F TRANSCRIPTIONAL TARGETS AT G1 S | 0 | 1 | 1 | 21 | 0 |
| EARLY PHASE OF HIV LIFE CYCLE | 0 | 1 | 1 | 13 | 0 |
| EGFR DOWNREGULATION | 0 | 1 | 1 | 24 | 0 |
| EICOSANOID LIGAND BINDING RECEPTORS | 0 | 1 | 1 | 15 | 0 |
| ELECTRON TRANSPORT CHAIN | 0 | 1 | 1 | 74 | 0 |
| ELONGATION AND PROCESSING OF CAPPED TRANSCRIPTS | 0 | 1 | 1 | 133 | 0 |
| ENDOGENOUS STEROLS | 0 | 1 | 1 | 14 | 0 |
| ERK MAPK TARGETS | 0 | 1 | 1 | 21 | 0 |
| EXTENSION OF TELOMERES | 0 | 1 | 1 | 28 | 0 |
| FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | 0 | 1 | 1 | 12 | 0 |
| FANCONI ANEMIA PATHWAY | 0 | 1 | 1 | 17 | 0 |
| FGFR LIGAND BINDING AND ACTIVATION | 0 | 1 | 1 | 26 | 0 |
| FORMATION AND MATURATION OF MRNA TRANSCRIPT | 0 | 1 | 1 | 151 | 0 |
| FORMATION OF A POOL OF FREE 40S SUBUNITS | 0 | 1 | 1 | 95 | 0 |
| FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | 0 | 1 | 1 | 15 | 0 |
| FORMATION OF FIBRIN CLOT CLOTTING CASCADE | 0 | 1 | 1 | 32 | 0 |
| FORMATION OF PLATELET PLUG | 0 | 1 | 1 | 179 | 0 |
| FORMATION OF THE EARLY ELONGATION COMPLEX | 0 | 1 | 1 | 31 | 0 |
| FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | 0 | 1 | 1 | 49 | 0 |
| FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | 0 | 1 | 1 | 20 | 0 |
| FRS2 MEDIATED ACTIVATION | 0 | 1 | 1 | 16 | 0 |
| FURTHER PLATELET RELEASATE | 0 | 1 | 1 | 21 | 0 |
| G ALPHA 12 13 SIGNALLING EVENTS | 0 | 1 | 1 | 54 | 0 |
| G ALPHA I SIGNALLING EVENTS | 0 | 1 | 1 | 174 | 0 |
| G ALPHA Q SIGNALLING EVENTS | 0 | 1 | 1 | 154 | 0 |
| G ALPHA S SIGNALLING EVENTS | 0 | 1 | 1 | 123 | 0 |
| G ALPHA Z SIGNALLING EVENTS | 0 | 1 | 1 | 14 | 0 |
| G PROTEIN ACTIVATION | 0 | 1 | 1 | 28 | 0 |
| G PROTEIN BETA GAMMA SIGNALLING | 0 | 1 | 1 | 27 | 0 |
| G1 PHASE | 0 | 1 | 1 | 16 | 0 |
| G1 S TRANSITION | 0 | 1 | 1 | 101 | 0 |
| G2 M CHECKPOINTS | 0 | 1 | 1 | 42 | 0 |
| G2 M TRANSITION | 0 | 1 | 1 | 80 | 0 |
| GAB1 SIGNALOSOME | 0 | 1 | 1 | 11 | 0 |
| GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | 0 | 1 | 1 | 10 | 0 |
| GENE EXPRESSION | 0 | 1 | 1 | 419 | 0 |
| GENERATION OF SECOND MESSENGER MOLECULES | 0 | 1 | 1 | 33 | 0 |
| GENERIC TRANSCRIPTION PATHWAY | 0 | 1 | 1 | 35 | 0 |
| GENES INVOLVED IN APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | 0 | 1 | 1 | 37 | 0 |
| GLOBAL GENOMIC NER | 0 | 1 | 1 | 32 | 0 |
| GLUCAGON SIGNALING IN METABOLIC REGULATION | 0 | 1 | 1 | 34 | 0 |
| GLUCAGON TYPE LIGAND RECEPTORS | 0 | 1 | 1 | 33 | 0 |
| GLUCONEOGENESIS | 0 | 1 | 1 | 31 | 0 |
| GLUCOSE AND OTHER SUGAR SLC TRANSPORTERS | 0 | 1 | 1 | 80 | 0 |
| GLUCOSE METABOLISM | 0 | 1 | 1 | 54 | 0 |
| GLUCOSE REGULATION OF INSULIN SECRETION | 0 | 1 | 1 | 159 | 0 |
| GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | 0 | 1 | 1 | 15 | 0 |
| GLUTATHIONE CONJUGATION | 0 | 1 | 1 | 17 | 0 |
| GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | 0 | 1 | 1 | 14 | 0 |
| GLYCOLYSIS | 0 | 1 | 1 | 22 | 0 |
| GOLGI ASSOCIATED VESICLE BIOGENESIS | 0 | 1 | 1 | 53 | 0 |
| GRB2 EVENTS IN EGFR SIGNALING | 0 | 1 | 1 | 13 | 0 |
| GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | 0 | 1 | 1 | 15 | 0 |
| GS ALPHA MEDIATED EVENTS IN GLUCAGON SIGNALLING | 0 | 1 | 1 | 27 | 0 |
| GTP HYDROLYSIS AND JOINING OF THE 60S RIBOSOMAL SUBUNIT | 0 | 1 | 1 | 106 | 0 |
| HDL MEDIATED LIPID TRANSPORT | 0 | 1 | 1 | 11 | 0 |
| HEMOSTASIS | 0 | 1 | 1 | 266 | 0 |
| HIV INFECTION | 0 | 1 | 1 | 180 | 0 |
| HIV LIFE CYCLE | 0 | 1 | 1 | 100 | 0 |
| HIV1 TRANSCRIPTION ELONGATION | 0 | 1 | 1 | 40 | 0 |
| HIV1 TRANSCRIPTION INITIATION | 0 | 1 | 1 | 38 | 0 |
| HOMOLOGOUS RECOMBINATION REPAIR | 0 | 1 | 1 | 14 | 0 |
| HORMONE BIOSYNTHESIS | 0 | 1 | 1 | 50 | 0 |
| HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | 0 | 1 | 1 | 12 | 0 |
| HOST INTERACTIONS OF HIV FACTORS | 0 | 1 | 1 | 118 | 0 |
| IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | 0 | 1 | 1 | 66 | 0 |
| INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX | 0 | 1 | 1 | 18 | 0 |
| INFLUENZA LIFE CYCLE | 0 | 1 | 1 | 134 | 0 |
| INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | 0 | 1 | 1 | 100 | 0 |
| INITIAL TRIGGERING OF COMPLEMENT | 0 | 1 | 1 | 13 | 0 |
| INNATE IMMUNITY SIGNALING | 0 | 1 | 1 | 105 | 0 |
| INORGANIC CATION ANION SLC TRANSPORTERS | 0 | 1 | 1 | 93 | 0 |
| INSULIN SYNTHESIS AND SECRETION | 0 | 1 | 1 | 128 | 0 |
| INTEGRATION OF ENERGY METABOLISM | 0 | 1 | 1 | 226 | 0 |
| INTEGRIN ALPHAIIBBETA3 SIGNALING | 0 | 1 | 1 | 23 | 0 |
| INTEGRIN CELL SURFACE INTERACTIONS | 0 | 1 | 1 | 80 | 0 |
| INTRINSIC PATHWAY | 0 | 1 | 1 | 17 | 0 |
| INTRINSIC PATHWAY FOR APOPTOSIS | 0 | 1 | 1 | 29 | 0 |
| IRS RELATED EVENTS | 0 | 1 | 1 | 77 | 0 |
| LAGGING STRAND SYNTHESIS | 0 | 1 | 1 | 20 | 0 |
| LATE PHASE OF HIV LIFE CYCLE | 0 | 1 | 1 | 87 | 0 |
| LIPOPROTEIN METABOLISM | 0 | 1 | 1 | 27 | 0 |
| LOSS OF NLP FROM MITOTIC CENTROSOMES | 0 | 1 | 1 | 60 | 0 |
| LYSOSOME VESICLE BIOGENESIS | 0 | 1 | 1 | 24 | 0 |
| M G1 TRANSITION | 0 | 1 | 1 | 61 | 0 |
| MEMBRANE TRAFFICKING | 0 | 1 | 1 | 77 | 0 |
| METABLISM OF NUCLEOTIDES | 0 | 1 | 1 | 70 | 0 |
| METABOLISM OF AMINO ACIDS | 0 | 1 | 1 | 160 | 0 |
| METABOLISM OF BILE ACIDS AND BILE SALTS | 0 | 1 | 1 | 27 | 0 |
| METABOLISM OF CARBOHYDRATES | 0 | 1 | 1 | 113 | 0 |
| METABOLISM OF LIPIDS AND LIPOPROTEINS | 0 | 1 | 1 | 225 | 0 |
| METABOLISM OF NITRIC OXIDE | 0 | 1 | 1 | 11 | 0 |
| METABOLISM OF PROTEINS | 0 | 1 | 1 | 211 | 0 |
| METABOLISM OF VITAMINS AND COFACTORS | 0 | 1 | 1 | 42 | 0 |
| MICRORNA BIOGENESIS | 0 | 1 | 1 | 18 | 0 |
| MITOCHONDRIAL FATTY ACID BETA OXIDATION | 0 | 1 | 1 | 10 | 0 |
| MITOCHONDRIAL TRNA AMINOACYLATION | 0 | 1 | 1 | 18 | 0 |
| MITOTIC PROMETAPHASE | 0 | 1 | 1 | 91 | 0 |
| MRNA 3 END PROCESSING | 0 | 1 | 1 | 34 | 0 |
| MRNA PROCESSING | 0 | 1 | 1 | 31 | 0 |
| MRNA SPLICING | 0 | 1 | 1 | 107 | 0 |
| MRNA SPLICING MINOR PATHWAY | 0 | 1 | 1 | 42 | 0 |
| MTOR SIGNALLING | 0 | 1 | 1 | 27 | 0 |
| MTORC1 MEDIATED SIGNALLING | 0 | 1 | 1 | 11 | 0 |
| MUSCLE CONTRACTION | 0 | 1 | 1 | 47 | 0 |
| MYD88 CASCADE | 0 | 1 | 1 | 19 | 0 |
| NCAM SIGNALING FOR NEURITE OUT GROWTH | 0 | 1 | 1 | 68 | 0 |
| NCAM1 INTERACTIONS | 0 | 1 | 1 | 43 | 0 |
| NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | 0 | 1 | 1 | 10 | 0 |
| NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPT | 0 | 1 | 1 | 21 | 0 |
| NEURORANSMITTER RECEPTOR BINDING AND DOWNSTREAM TRANSMISSION IN THE POSTSYNAPTIC CELL | 0 | 1 | 1 | 80 | 0 |
| NEUROTRANSMITTER RELEASE CYCLE | 0 | 1 | 1 | 27 | 0 |
| NF KB IS ACTIVATED AND SIGNALS SURVIVAL | 0 | 1 | 1 | 10 | 0 |
| NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | 0 | 1 | 1 | 12 | 0 |
| NOTCH HLH TRANSCRIPTION PATHWAY | 0 | 1 | 1 | 13 | 0 |
| NRAGE SIGNALS DEATH THROUGH JNK | 0 | 1 | 1 | 47 | 0 |
| NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | 0 | 1 | 1 | 13 | 0 |
| NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | 0 | 1 | 1 | 24 | 0 |
| NUCLEAR IMPORT OF REV PROTEIN | 0 | 1 | 1 | 29 | 0 |
| NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | 0 | 1 | 1 | 50 | 0 |
| NUCLEOTIDE EXCISION REPAIR | 0 | 1 | 1 | 48 | 0 |
| NUCLEOTIDE LIKE PURINERGIC RECEPTORS | 0 | 1 | 1 | 17 | 0 |
| OLFACTORY SIGNALING PATHWAY | 0 | 1 | 1 | 316 | 0 |
| OPIOID SIGNALLING | 0 | 1 | 1 | 81 | 0 |
| ORC1 REMOVAL FROM CHROMATIN | 0 | 1 | 1 | 63 | 0 |
| OTHER SEMAPHORIN INTERACTIONS | 0 | 1 | 1 | 16 | 0 |
| P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | 0 | 1 | 1 | 15 | 0 |
| P2Y RECEPTORS | 0 | 1 | 1 | 13 | 0 |
| P38MAPK EVENTS | 0 | 1 | 1 | 13 | 0 |
| P53 INDEPENDENT DNA DAMAGE RESPONSE | 0 | 1 | 1 | 43 | 0 |
| P75 NTR RECEPTOR MEDIATED SIGNALLING | 0 | 1 | 1 | 82 | 0 |
| P75NTR RECRUITS SIGNALLING COMPLEXES | 0 | 1 | 1 | 10 | 0 |
| P75NTR SIGNALS VIA NFKB | 0 | 1 | 1 | 13 | 0 |
| PACKAGING OF TELOMERE ENDS | 0 | 1 | 1 | 29 | 0 |
| PD1 SIGNALING | 0 | 1 | 1 | 25 | 0 |
| PECAM1 INTERACTIONS | 0 | 1 | 1 | 10 | 0 |
| PEPTIDE CHAIN ELONGATION | 0 | 1 | 1 | 84 | 0 |
| PEPTIDE LIGAND BINDING RECEPTORS | 0 | 1 | 1 | 172 | 0 |
| PEROXISOMAL LIPID METABOLISM | 0 | 1 | 1 | 19 | 0 |
| PHASE 1 FUNCTIONALIZATION | 0 | 1 | 1 | 15 | 0 |
| PHASE 1 FUNCTIONALIZATION OF COMPOUNDS | 0 | 1 | 1 | 64 | 0 |
| PHASE II CONJUGATION | 0 | 1 | 1 | 59 | 0 |
| PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | 0 | 1 | 1 | 22 | 0 |
| PHOSPHORYLATION OF THE APC | 0 | 1 | 1 | 16 | 0 |
| PI3K AKT SIGNALLING | 0 | 1 | 1 | 37 | 0 |
| PKA ACTIVATION | 0 | 1 | 1 | 17 | 0 |
| PLATELET ACTIVATION | 0 | 1 | 1 | 160 | 0 |
| PLATELET ACTIVATION TRIGGERS | 0 | 1 | 1 | 57 | 0 |
| PLATELET ADHESION TO EXPOSED COLLAGEN | 0 | 1 | 1 | 13 | 0 |
| PLATELET AGGREGATION PLUG FORMATION | 0 | 1 | 1 | 26 | 0 |
| PLATELET DEGRANULATION | 0 | 1 | 1 | 82 | 0 |
| PLC BETA MEDIATED EVENTS | 0 | 1 | 1 | 36 | 0 |
| PLC GAMMA1 SIGNALLING | 0 | 1 | 1 | 33 | 0 |
| POLYMERASE SWITCHING | 0 | 1 | 1 | 14 | 0 |
| POST CHAPERONIN TUBULIN FOLDING PATHWAY | 0 | 1 | 1 | 17 | 0 |
| POST TRANSLATIONAL PROTEIN MODIFICATION | 0 | 1 | 1 | 40 | 0 |
| PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | 0 | 1 | 1 | 26 | 0 |
| PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | 0 | 1 | 1 | 137 | 0 |
| PROSTANOID HORMONES | 0 | 1 | 1 | 11 | 0 |
| PURINE METABOLISM | 0 | 1 | 1 | 30 | 0 |
| PURINE SALVAGE REACTIONS | 0 | 1 | 1 | 12 | 0 |
| PYRIMIDINE METABOLISM | 0 | 1 | 1 | 22 | 0 |
| PYRUVATE METABOLISM | 0 | 1 | 1 | 18 | 0 |
| PYRUVATE METABOLISM AND TCA CYCLE | 0 | 1 | 1 | 36 | 0 |
| RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | 0 | 1 | 1 | 10 | 0 |
| RECYCLING OF BILE ACIDS AND SALTS | 0 | 1 | 1 | 11 | 0 |
| REGULATED PROTEOLYSIS OF P75NTR | 0 | 1 | 1 | 11 | 0 |
| REGULATION OF APC ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE | 0 | 1 | 1 | 70 | 0 |
| REGULATION OF BETA CELL DEVELOPMENT | 0 | 1 | 1 | 113 | 0 |
| REGULATION OF GENE EXPRESSION IN BETA CELLS | 0 | 1 | 1 | 100 | 0 |
| REGULATION OF INSULIN LIKE GROWTH FACTOR ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PRO | 0 | 1 | 1 | 17 | 0 |
| REGULATION OF INSULIN SECRETION | 0 | 1 | 1 | 210 | 0 |
| REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | 0 | 1 | 1 | 21 | 0 |
| REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE 1 | 0 | 1 | 1 | 60 | 0 |
| REGULATION OF LIPID METABOLISM BY PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA | 0 | 1 | 1 | 61 | 0 |
| REGULATION OF ORNITHINE DECARBOXYLASE | 0 | 1 | 1 | 47 | 0 |
| REMOVAL OF DNA PATCH CONTAINING ABASIC RESIDUE | 0 | 1 | 1 | 15 | 0 |
| REMOVAL OF THE FLAP INTERMEDIATE | 0 | 1 | 1 | 14 | 0 |
| REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | 0 | 1 | 1 | 10 | 0 |
| REPAIR SYNTHESIS OF PATCH 27 30 BASES LONG BY DNA POLYMERASE | 0 | 1 | 1 | 15 | 0 |
| RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | 0 | 1 | 1 | 12 | 0 |
| REV MEDIATED NUCLEAR EXPORT OF HIV1 RNA | 0 | 1 | 1 | 29 | 0 |
| RHO GTPASE CYCLE | 0 | 1 | 1 | 123 | 0 |
| RNA POL II CTD PHOSPHORYLATION AND INTERACTION WITH CE | 0 | 1 | 1 | 25 | 0 |
| RNA POLYMERASE I CHAIN ELONGATION | 0 | 1 | 1 | 22 | 0 |
| RNA POLYMERASE I PROMOTER CLEARANCE | 0 | 1 | 1 | 50 | 0 |
| RNA POLYMERASE I PROMOTER ESCAPE | 0 | 1 | 1 | 19 | 0 |
| RNA POLYMERASE I TRANSCRIPTION INITIATION | 0 | 1 | 1 | 23 | 0 |
| RNA POLYMERASE I TRANSCRIPTION TERMINATION | 0 | 1 | 1 | 20 | 0 |
| RNA POLYMERASE II TRANSCRIPTION | 0 | 1 | 1 | 91 | 0 |
| RNA POLYMERASE III CHAIN ELONGATION | 0 | 1 | 1 | 12 | 0 |
| RNA POLYMERASE III TRANSCRIPTION | 0 | 1 | 1 | 33 | 0 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION | 0 | 1 | 1 | 28 | 0 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | 0 | 1 | 1 | 20 | 0 |
| RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | 0 | 1 | 1 | 21 | 0 |
| RNA POLYMERASE III TRANSCRIPTION TERMINATION | 0 | 1 | 1 | 17 | 0 |
| S PHASE | 0 | 1 | 1 | 103 | 0 |
| SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | 0 | 1 | 1 | 48 | 0 |
| SCF SKP2 MEDIATED DEGRADATION OF P27 P21 | 0 | 1 | 1 | 52 | 0 |
| SEMA3A PAK DEPENDENT AXON REPULSION | 0 | 1 | 1 | 15 | 0 |
| SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | 0 | 1 | 1 | 14 | 0 |
| SEMA4D IN SEMAPHORIN SIGNALING | 0 | 1 | 1 | 29 | 0 |
| SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | 0 | 1 | 1 | 24 | 0 |
| SEMAPHORIN INTERACTIONS | 0 | 1 | 1 | 66 | 0 |
| SEROTONIN NEUROTRANSMITTER RELEASE CYCLE | 0 | 1 | 1 | 13 | 0 |
| SEROTONIN RECEPTORS | 0 | 1 | 1 | 12 | 0 |
| SHC MEDIATED SIGNALLING | 0 | 1 | 1 | 12 | 0 |
| SHC RELATED EVENTS | 0 | 1 | 1 | 13 | 0 |
| SIGNAL ATTENUATION | 0 | 1 | 1 | 10 | 0 |
| SIGNALING BY BMP | 0 | 1 | 1 | 23 | 0 |
| SIGNALING BY EGFR | 0 | 1 | 1 | 48 | 0 |
| SIGNALING BY NOTCH | 0 | 1 | 1 | 16 | 0 |
| SIGNALING BY PDGF | 0 | 1 | 1 | 64 | 0 |
| SIGNALING BY ROBO RECEPTOR | 0 | 1 | 1 | 32 | 0 |
| SIGNALING BY TGF BETA | 0 | 1 | 1 | 15 | 0 |
| SIGNALING BY VEGF | 0 | 1 | 1 | 11 | 0 |
| SIGNALING BY WNT | 0 | 1 | 1 | 58 | 0 |
| SIGNALING IN IMMUNE SYSTEM | 0 | 1 | 1 | 322 | 0 |
| SIGNALLING BY NGF | 0 | 1 | 1 | 213 | 0 |
| SIGNALLING TO ERKS | 0 | 1 | 1 | 34 | 0 |
| SIGNALLING TO P38 VIA RIT AND RIN | 0 | 1 | 1 | 14 | 0 |
| SIGNALLING TO RAS | 0 | 1 | 1 | 26 | 0 |
| SLC MEDIATED TRANSMEMBRANE TRANSPORT | 0 | 1 | 1 | 166 | 0 |
| SNRNP ASSEMBLY | 0 | 1 | 1 | 48 | 0 |
| SOS MEDIATED SIGNALLING | 0 | 1 | 1 | 13 | 0 |
| SPHINGOLIPID METABOLISM | 0 | 1 | 1 | 32 | 0 |
| STEROID HORMONE BIOSYNTHESIS | 0 | 1 | 1 | 14 | 0 |
| STEROID HORMONES | 0 | 1 | 1 | 21 | 0 |
| STEROID METABOLISM | 0 | 1 | 1 | 62 | 0 |
| STRIATED MUSCLE CONTRACTION | 0 | 1 | 1 | 29 | 0 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS | 0 | 1 | 1 | 19 | 0 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | 0 | 1 | 1 | 10 | 0 |
| SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | 0 | 1 | 1 | 15 | 0 |
| SYNTHESIS OF DNA | 0 | 1 | 1 | 89 | 0 |
| SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL | 0 | 1 | 1 | 17 | 0 |
| SYNTHESIS OF GPI ANCHORED PROTEINS | 0 | 1 | 1 | 26 | 0 |
| TAT MEDIATED HIV1 ELONGATION ARREST AND RECOVERY | 0 | 1 | 1 | 30 | 0 |
| TCR SIGNALING | 0 | 1 | 1 | 60 | 0 |
| TELOMERE MAINTENANCE | 0 | 1 | 1 | 57 | 0 |
| THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | 0 | 1 | 1 | 28 | 0 |
| TIE2 SIGNALING | 0 | 1 | 1 | 18 | 0 |
| TIGHT JUNCTION INTERACTIONS | 0 | 1 | 1 | 29 | 0 |
| TOLL LIKE RECEPTOR 3 CASCADE | 0 | 1 | 1 | 59 | 0 |
| TOLL LIKE RECEPTOR 4 CASCADE | 0 | 1 | 1 | 27 | 0 |
| TOLL LIKE RECEPTOR 9 CASCADE | 0 | 1 | 1 | 23 | 0 |
| TOLL RECEPTOR CASCADES | 0 | 1 | 1 | 85 | 0 |
| TRAF6 MEDIATED INDUCTION OF THE ANTIVIRAL CYTOKINE IFN ALPHA BETA CASCADE | 0 | 1 | 1 | 53 | 0 |
| TRAFFICKING OF AMPA RECEPTORS | 0 | 1 | 1 | 29 | 0 |
| TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | 0 | 1 | 1 | 15 | 0 |
| TRANSCRIPTION | 0 | 1 | 1 | 164 | 0 |
| TRANSCRIPTION COUPLED NER | 0 | 1 | 1 | 43 | 0 |
| TRANSCRIPTION OF THE HIV GENOME | 0 | 1 | 1 | 58 | 0 |
| TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL | 0 | 1 | 1 | 10 | 0 |
| TRANSLATION | 0 | 1 | 1 | 119 | 0 |
| TRANSLATION INITIATION COMPLEX FORMATION | 0 | 1 | 1 | 56 | 0 |
| TRANSLOCATION OF ZAP70 TO IMMUNOLOGICAL SYNAPSE | 0 | 1 | 1 | 20 | 0 |
| TRANSMEMBRANE TRANSPORT OF SMALL MOLECULES | 0 | 1 | 1 | 213 | 0 |
| TRANSMISSION ACROSS CHEMICAL SYNAPSES | 0 | 1 | 1 | 125 | 0 |
| TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRON CONTAINING TRANSCRIPT | 0 | 1 | 1 | 50 | 0 |
| TRIACYLGLYCERIDE BIOSYNTHESIS | 0 | 1 | 1 | 13 | 0 |
| TRKA SIGNALLING FROM THE PLASMA MEMBRANE | 0 | 1 | 1 | 101 | 0 |
| TRNA AMINOACYLATION | 0 | 1 | 1 | 37 | 0 |
| UNFOLDED PROTEIN RESPONSE | 0 | 1 | 1 | 19 | 0 |
| UNWINDING OF DNA | 0 | 1 | 1 | 11 | 0 |
| VIF MEDIATED DEGRADATION OF APOBEC3G | 0 | 1 | 1 | 47 | 0 |
| VIRAL DSRNA TLR3 TRIF COMPLEX ACTIVATES RIP1 | 0 | 1 | 1 | 12 | 0 |
| VIRAL MESSENGER RNA SYNTHESIS | 0 | 1 | 1 | 14 | 0 |
| VIRAL MRNA TRANSLATION | 0 | 1 | 1 | 84 | 0 |
| VPR MEDIATED NUCLEAR IMPORT OF PICS | 0 | 1 | 1 | 30 | 0 |
| XENOBIOTICS | 0 | 1 | 1 | 15 | 0 |
| ACTIVATION OF RAC | 0 | 1 | 1 | 14 | 0 |
| PP2A MEDIATED DEPHOSPHORYLATION OF KEY METABOLIC FACTORS | 0 | 1 | 1 | 10 | 0 |
| REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | 0 | 1 | 1 | 10 | 0 |
| ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | 0 | 1 | 1 | 10 | 0 |
| SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | 0 | 1 | 1 | 17 | 0 |
| TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | 0 | 1 | 1 | 28 | 0 |
| BOTULINUM NEUROTOXICITY | 0 | 1 | 1 | 18 | 0 |
| JNK PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | 0 | 1 | 1 | 12 | 0 |
| CREB PHOPHORYLATION THROUGH THE ACTIVATION OF RAS | 0 | 1 | 1 | 23 | 0 |
| POST NMDA RECEPTOR ACTIVATION EVENTS | 0 | 1 | 1 | 29 | 0 |
| RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | 0 | 1 | 1 | 15 | 0 |
| CDC6 ASSOCIATION WITH THE ORC:ORIGIN COMPLEX | 0 | 1 | 1 | 11 | 0 |
| CELLEXTRACELLULAR MATRIX INTERACTIONS | 0 | 1 | 1 | 16 | 0 |
| GLUCOSE TRANSPORT | 0 | 1 | 1 | 36 | 0 |
| ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12 | 0 | 1 | 1 | 21 | 0 |
| DEADENYLATION OF MRNA | 0 | 1 | 1 | 22 | 0 |
| BETACATENIN PHOSPHORYLATION CASCADE | 0 | 1 | 1 | 13 | 0 |
| MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | 0 | 1 | 1 | 12 | 0 |
| AMINE COMPOUND SLC TRANSPORTERS | 0 | 1 | 1 | 28 | 0 |
| BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | 0 | 1 | 1 | 12 | 0 |
| REGULATION OF INSULIN SECRETION BY FREE FATTY ACIDS | 0 | 1 | 1 | 19 | 0 |
| FRS2MEDIATED CASCADE | 0 | 1 | 1 | 26 | 0 |
| GAP JUNCTION TRAFFICKING | 0 | 1 | 1 | 21 | 0 |
| REGULATION OF GLUCOKINASE BY GLUCOKINASE REGULATORY PROTEIN | 0 | 1 | 1 | 28 | 0 |
| GLUCURONIDATION | 0 | 1 | 1 | 19 | 0 |
| EFFECTS OF PIP2 HYDROLYSIS | 0 | 1 | 1 | 15 | 0 |
| PYRIMIDINE CATABOLISM | 0 | 1 | 1 | 10 | 0 |
| SIGNAL AMPLIFICATION | 0 | 1 | 1 | 31 | 0 |
| ACTIVATION OF CHAPERONES BY IRE1 ALPHA | 0 | 1 | 1 | 10 | 0 |
| IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | 0 | 1 | 1 | 10 | 0 |
| ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | 0 | 1 | 1 | 30 | 0 |
| STABILIZATION OF P53 | 0 | 1 | 1 | 46 | 0 |
| REGULATION OF AMPK ACTIVITY VIA LKB1 | 0 | 1 | 1 | 14 | 0 |
| ERKS ARE INACTIVATED | 0 | 1 | 1 | 12 | 0 |
| MAP KINASES ACTIVATION IN TLR CASCADE | 0 | 1 | 1 | 44 | 0 |
| RETROGRADE NEUROTROPHIN SIGNALLING | 0 | 1 | 1 | 12 | 0 |
| HUMAN TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | 0 | 1 | 1 | 15 | 0 |
| ACTIVATION OF NMDA RECEPTOR UPON GLUTAMATE BINDING AND POSTSYNAPTIC EVENTS | 0 | 1 | 1 | 33 | 0 |
| ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | 0 | 1 | 1 | 13 | 0 |
| VITAMIN B5 (PANTOTHENATE) METABOLISM | 0 | 1 | 1 | 11 | 0 |
| G BETA GAMMA SIGNALLING THROUGH PLC BETA | 0 | 1 | 1 | 20 | 0 |
| G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | 0 | 1 | 1 | 24 | 0 |
| METAL ION SLC TRANSPORTERS | 0 | 1 | 1 | 22 | 0 |
| SHCMEDIATED CASCADE | 0 | 1 | 1 | 20 | 0 |
| PI3K CASCADE | 0 | 1 | 1 | 36 | 0 |
| DEPOLARIZATION OF THE PRESYNAPTIC TERMINAL TRIGGERS THE OPENING OF CALCIUM CHANNELS | 0 | 1 | 1 | 12 | 0 |
| RNA POLYMERASE I PROMOTER OPENING | 0 | 1 | 1 | 28 | 0 |
| GAP JUNCTION ASSEMBLY | 0 | 1 | 1 | 13 | 0 |
| INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | 0 | 1 | 1 | 29 | 0 |
| MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | 0 | 1 | 1 | 11 | 0 |
| ASSOCIATION OF LICENSING FACTORS WITH THE PREREPLICATIVE COMPLEX | 0 | 1 | 1 | 12 | 0 |
| REGULATION OF PYRUVATE DEHYDROGENASE COMPLEX | 0 | 1 | 1 | 12 | 0 |
| PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | 0 | 1 | 1 | 11 | 0 |
| NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | 0 | 1 | 1 | 18 | 0 |
| NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | 0 | 1 | 1 | 27 | 0 |
| GPCR LIGAND BINDING | 0 | 1 | 1 | 383 | 0 |
| AMINO ACID SYNTHESIS AND INTERCONVERSION | 0 | 1 | 1 | 12 | 0 |
| THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS | 0 | 1 | 1 | 27 | 0 |
| THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | 0 | 1 | 1 | 23 | 0 |
| RNA POLYMERASE I III AND MITOCHONDRIAL TRANSCRIPTION | 0 | 1 | 1 | 87 | 0 |
| TRANSPORT OF THE SLBP INDEPENDENT MATURE MRNA | 0 | 1 | 1 | 31 | 0 |
| ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | 0 | 1 | 1 | 28 | 0 |
| PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | 0 | 1 | 1 | 16 | 0 |
| ZINC TRANSPORTATION | 0 | 1 | 1 | 16 | 0 |
| APOPTOSIS INDUCED DNA FRAGMENTATION | 0 | 1 | 1 | 11 | 0 |
| SMOOTH MUSCLE CONTRACTION | 0 | 1 | 1 | 21 | 0 |
| METABOLISM OF MRNA | 0 | 1 | 1 | 45 | 0 |
| CELL JUNCTION ORGANIZATION | 0 | 1 | 1 | 83 | 0 |
| METABOLISM OF RNA | 0 | 1 | 1 | 93 | 0 |
| MITOTIC M M G1 PHASES | 0 | 1 | 1 | 156 | 0 |
| MYOGENESSIS | 0 | 1 | 1 | 29 | 0 |
| MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | 0 | 1 | 1 | 30 | 0 |
| DOWNSTREAM SIGNALING OF ACTIVATED FGFR | 0 | 1 | 1 | 41 | 0 |
| CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | 0 | 1 | 1 | 13 | 0 |
| PHOSPHOLIPASE CMEDIATED CASCADE | 0 | 1 | 1 | 22 | 0 |
| ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK | 0 | 1 | 1 | 17 | 0 |